Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haerim Chung

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Oncologist|April 6, 2024
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphomaYu Ri Kim, Hyunsoo Cho, Soo-Jeong Kim, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 16, 2020
PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cellsJi Eun Jang, Ju-In Eom, Hoi-Kyung Jeung, et al.
Hematological Oncology|July 22, 2016
Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphomaYundeok Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 13, 2020
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemiaDoh Yu Hwang, Ju-In Eom, Ji Eun Jang, et al.
Oncotarget|December 2, 2017
Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphomaYu Ri Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Cancers|February 11, 2023
DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK ActivationJi Eun Jang, Doh Yu Hwang, Ju-In Eom, et al.
British Journal of Haematology|May 4, 2022
Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaHyunsoo Cho, Saeam Shin, Haerim Chung, et al.
Cancer Research and Treatment|December 5, 2017
HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant LymphomaHyunsung Park, Do Young Kim, Soo-Jeong Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2019
Early Cytomegalovirus Reactivation and Expansion of CD56<sup>bright</sup>CD16<sup>dim/-</sup>DNAM1<sup>+</sup> Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute LeukemiaJi Eun Jang, Doh Yu Hwang, Haerim Chung, et al.
Cancer Cell International|May 19, 2024
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomesNamsoo Kim, Seungmin Hahn, Yu Jeong Choi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Oncologist|April 6, 2024
Clinical outcomes of etoposide and cytarabine as consolidation in elderly patients with primary CNS lymphomaYu Ri Kim, Hyunsoo Cho, Soo-Jeong Kim, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 16, 2020
PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cellsJi Eun Jang, Ju-In Eom, Hoi-Kyung Jeung, et al.
Hematological Oncology|July 22, 2016
Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphomaYundeok Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 13, 2020
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemiaDoh Yu Hwang, Ju-In Eom, Ji Eun Jang, et al.
Oncotarget|December 2, 2017
Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphomaYu Ri Kim, Soo-Jeong Kim, June-Won Cheong, et al.
Cancers|February 11, 2023
DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK ActivationJi Eun Jang, Doh Yu Hwang, Ju-In Eom, et al.
British Journal of Haematology|May 4, 2022
Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaHyunsoo Cho, Saeam Shin, Haerim Chung, et al.
Cancer Research and Treatment|December 5, 2017
HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant LymphomaHyunsung Park, Do Young Kim, Soo-Jeong Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2019
Early Cytomegalovirus Reactivation and Expansion of CD56<sup>bright</sup>CD16<sup>dim/-</sup>DNAM1<sup>+</sup> Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute LeukemiaJi Eun Jang, Doh Yu Hwang, Haerim Chung, et al.
Cancer Cell International|May 19, 2024
Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomesNamsoo Kim, Seungmin Hahn, Yu Jeong Choi, et al.
Pageof 4